These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23517282)

  • 21. Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels.
    Armstrong VW; Schleef J; Thiery J; Muche R; Schuff-Werner P; Eisenhauer T; Seidel D
    Eur J Clin Invest; 1989 Jun; 19(3):235-40. PubMed ID: 2509208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of cascade filtration plasmapheresis in two patients affected by familial hypercholesterolemia.
    Barbagallo CM; Averna MR; DiMarco T; Spano L; Scafidi V; Marino G; Camemi AR; Notarbartolo A
    J Clin Apher; 1995; 10(2):96-100. PubMed ID: 7592525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro characterization of two types of LDL apheresis module and effect of repetitive LDL apheresis on plasma cholesterol levels and aortic atherosclerosis in heterozygous WHHL rabbits.
    Kim SS; Kutsumi Y; Nakai T; Miyabo S
    Jpn Circ J; 1991 Jan; 55(1):68-80. PubMed ID: 2010950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol levels and long-term rates of community-acquired sepsis.
    Guirgis FW; Donnelly JP; Dodani S; Howard G; Safford MM; Levitan EB; Wang HE
    Crit Care; 2016 Dec; 20(1):408. PubMed ID: 28010729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis.
    Mabuchi H; Michishita I; Sakai T; Sakai Y; Watanabe A; Wakasugi T; Takeda R
    Atherosclerosis; 1986 Aug; 61(2):135-40. PubMed ID: 3463306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic analysis of cholesterol removal by thermofiltration.
    Malchesky PS; Werynski A; Nomura H; Yamashita M; Takeyama Y; Nosé Y
    ASAIO Trans; 1988; 34(4):965-8. PubMed ID: 3219258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the plasmapheresis donor in a voluntary, nonremunerated environment.
    Bove LL; Bednall T; Masser B; Buzza M
    Transfusion; 2011 Nov; 51(11):2411-24. PubMed ID: 21564104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994.
    Ferrara A; Barrett-Connor E; Shan J
    Circulation; 1997 Jul; 96(1):37-43. PubMed ID: 9236414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel approach to increasing inventory with the current panel: increasing donation frequency by asking for a different blood product.
    Bagot KL; Masser BM; White KM
    Transfusion; 2015 Jun; 55(6):1294-302. PubMed ID: 25652648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
    Riesen WF; Sturzenegger E; Imhof C; Descoeudres C; Mordasini R; Oetliker OH
    Prog Clin Biol Res; 1988; 255():337-46. PubMed ID: 3422496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.